68 results on '"Lang I."'
Search Results
2. (851) ARTISAN: A Novel Study of Mean Pulmonary Artery Pressure-Targeted Approach with Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Pulmonary Arterial Hypertension
3. INCREASED SUPAR SERUM CONCENTRATIONS IN PATIENTS WITH LEFT AND RIGHT VENTRICULAR REMODELING DUE TO PRESSURE OVERLOAD IS ASSOCIATED WITH MYOCARDIAL MASS
4. Gene expression profile at week 2 of neoadjuvant therapy course predicts outcome in HER2-positive breast cancer patients: an explorative analysis from NeoALTTO
5. Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication
6. Diagnostic performance of morphometric vertebral fracture analysis (MXA) in children using a 33-point software program
7. THE IMPACT OF TIME FROM DIAGNOSIS AT BASELINE ON LONG-TERM OUTCOME IN THE GRIPHON STUDY: SELEXIPAG IN PULMONARY ARTERIAL HYPERTENSION (PAH)
8. Cultivation of the microalga Eustigmatos magnus in different photobioreactor geometries and subsequent anaerobic digestion of pre-treated biomass
9. Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial
10. A two arm phase II study of FOLFIRI in combination with standard or escalating dose of cetuximab as first line treatment for metastatic colorectal cancer: Everest 2 final results
11. Physical activity: how well does systematic review evidence on physical activity interventions reflect the expressed views of older people?
12. An exploratory qualitative study examining the experiences of people with dementia receiving physiotherapy
13. Left Ventricular Diastolic Dysfunction in Patients With COPD in the Presence and Absence of Elevated Pulmonary Arterial Pressure
14. Evaluation of a semi-automated software program for the identification of vertebral fractures in children
15. Adjuvant anti-HER2 therapy, treatment-induced amenorrhea (TIA) and survival in premenopausal patients (pts) with HER2-positive (HER2+) early breast cancer (EBC): Analysis from the ALTTO trial (BIG 2-06)
16. Cibler la voie de la prostacycline dans le traitement des HTAP associées aux connectivites : expérience de Griphon – étude contrôlée, randomisée avec le selexipag
17. Physiotherapy interventions for people with dementia and a hip fracture – a scoping review of the literature
18. SELEXIPAG FOR PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL HEART DISEASE (PAH-CHD) AFTER DEFECT CORRECTION: INSIGHTS FROM THE RANDOMISED CONTROLLED GRIPHON STUDY
19. Phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H vs EU-neulasta® in the prophylaxis of chemotherapy-induced neutropenia
20. Safety of everolimus plus exemestane in patients with hormone-receptor–positive, HER2–negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)
21. Two-stage cultivation of N-rich and N-deprived Acutodesmus obliquus biomass: Influence of cultivation and dewatering methods on microalgal biomass used in anaerobic digestion
22. Anticoagulant Therapy Is Not Associated with Long Term Outcome in Patients with Pulmonary Arterial Hypertension (PAH): Insights from the GRIPHON Study
23. 1850 Safety of everolimus plus exemestane in elderly patients with Hormone-Receptor-Positive (HR+), HER2- locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors (NSAIs): BALLET (CRAD001YIC04)
24. 2365 Nanoliposomal irinotecan (MM-398, nal-IRI) population pharmacokinetics (PK) and its association with efficacy and safety in patients with solid tumors based on the phase 3 study NAPOLI-1 and five phase 1 and 2 studies
25. 1800 Final results for overall survival (OS), the primary endpoint of the CECOG TURANDOT prospective randomised trial evaluating bevacizumab-paclitaxel (BEV-PAC) vs BEV-capecitabine (CAP) for HER2-negative locally recurrent/metastatic breast cancer (LR/mBC)
26. Tryptophan regulates the chorionic vascular tone and chorionic endothelial indoleamine 2,3-dioxygenase-1 is deficient in intrauterine growth restriction and preeclampsia
27. The fetal hypoxic environment of GDM alters VEGF and FGF2 receptors in the venous but not arterial feto-placental vasculature
28. Effect of Selexipag on Morbidity/Mortality in Pulmonary Arterial Hypertension: Results of the GRIPHON Study
29. Liver-x receptor agonists modulate hdl and amyloid-beta metabolism in brain capillary endothelial cells forming the blood-brain barrier
30. Mesenchymal stromal cells from the human placenta promote neovascularization in a mouse model in vivo
31. Phase II Study of Palbociclib (PD-0332991) + Letrozole vs Letrozole Alone in First-Line ER + /HER2- Advanced Breast Cancer
32. Cost effectiveness of Sativex for spasticity in multiple sclerosis
33. Safety results from a phase III study (TURANDOT trial by CECOG) of first-line bevacizumab in combination with capecitabine or paclitaxel for HER-2-negative locally recurrent or metastatic breast cancer
34. 114 Alpha-Ketoglutarate, 5-hydroxy-methylfurfurale and Angiotensin 1-7: Cardioprotective Effects During Myocardial Ischemia/Reperfusion
35. First Efficacy Results From the Turandot Phase III Trial Comparing Two Bevacizumab (BEV)-Containing Regimens as First-Line Therapy for HER2-Negative Metastatic Breast Cancer (MBC)
36. Non Inferiority Analysis of Multicenter Phase III Comparing Cisplatin/S-1 (CS) with Cisplatin/5-Fu (CF) as First-Line Therapy in Patients with advanced Gastric Cancer (FLAGS): Methodology and Results
37. 100O Results of A Randomized Phase 2 Study of Pd 0332991, A Cyclin-Dependent Kinase (Cdk) 4/6 Inhibitor, In Combination with Letrozole vs Letrozole Alone For First-Line Treatment of ER + /Her2- Advanced Breast Cancer (Bc)
38. 358 Pulmonary Vascular Gradient: A Predictor of Prognosis in Pulmonary Hypertension Due to Left Heart Disease
39. 829 Care Organisation for Pulmonary Arterial Hypertension in Developed Countries: A Survey
40. 347 The Impact of Chemotherapeutic Regimens On the Cost-utility Analysis of Oncotype DX Assay
41. Amnionic mesenchymal stromal cells (AMSC) show a mesenchymal-epithelial phenotype and adopt endothelial characteristics under angiogenic conditions
42. 5053 POSTER Randomized Phase III Study of First-line Bevacizumab in Combination With Capecitabine or Paclitaxel for HER2-negative LR/MBC: Interim Safety Data
43. Expression of indoleamine 2,3-dioxygenase 1 in the vascular endothelium at both sides of the feto-maternal interface
44. 6078 Cetuximab plus FOLFIRI in 1st-line treatment of metastatic colorectal cancer: Quality of life (QoL) analysis of patients (pts) with KRAS wild-type (wt) tumours in the CRYSTAL trial
45. 5058 Bevacizumab (Bev) combined with either capecitabine (X) or weekly paclitaxel (Pac) as first-line therapy for HER2-negative locally recurrent or metastatic breast cancer (LR/MBC): the CECOG phase III TURANDOT trial
46. IFPA Meeting 2008 Workshops Report
47. Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015
48. 2078 POSTER Retrospective analysis of routine preoperative chemotherapy on effectivity and survival of 61 inflammatory breast cancer patients
49. Was John Reid right? Smoking, class, and pleasure: A population-based cohort study in England
50. The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.